ELIMINATION OF AZLOCILLIN IN PATIENTS WITH BILIARY T-TUBE DRAINAGEGUNDERT REMY U; WEBER E.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 5; PP. 435-439; BIBL. 17 REF.Article

DEGRADATION VON AZLOCILLIN UND MEZLOCILLIN. I: VERHALTEN IN BIOLOGISCHEM MATERIAL UND PUFFER = LA DEGRADATION DE L'AZLOCILLINE ET DE LA MEZLOCILLINE. I. COMPORTEMENT DANS LE MATERIEL BIOLOGIQUE ET DANS UN TAMPONGUNDERT REMY U; WEBER E.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 2; PP. 2041-2044; ABS. ENG; BIBL. 12 REF.Article

DETERMINATION OF THE UREIDOPENICILLINS AZLOCILLIN, MEZLOCILLIN AND BAY K 4999 IN PLASMA BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHYGUNDERT REMY U; DE VRIES JX.1979; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1979; VOL. 8; NO 6; PP. 589-592; BIBL. 5 REF.Article

Assessment of bioavailability using pharmacodynamic dataGUNDERT-REMY, U.S.T.P. pharma. 1987, Vol 3, Num 6, pp 519-521Conference Paper

³H-CYMAROL IN MAN: EXCRETION PATHWAYS AND SERUM PROTEIN BINDING.GUNDERT REMY U; WEBER E; RABL W et al.1978; ARZTL. FORSCH.; DEU; DA. 1978; NO 2; PP. 1174-1176; ABS. GER; BIBL. 7 REF.Article

Binding of theophylline and its metabolites to human plasma proteinsGUNDERT-REMY, U; HILDEBRANDT, R.British journal of clinical pharmacology. 1983, Vol 16, Num 5, pp 573-574, issn 0306-5251Article

ZUR RESORPTION VON PHENOBARBITAL AUS VERSCHIEDENEN DARREICHUNGSFORMEN. = RESORPTION DU PHENOBARBITAL A PARTIR DE DIFFERENTES FORMES PHARMACEUTIQUESGUNDERT REMY U; BILZER W; KILGENSTEIN R et al.1975; PHARM. INDUSTR.; DTSCH.; DA. 1975; VOL. 37; NO 11; PP. 905-909; ABS. ANGL.; BIBL. 10 REF.Article

BIOLOGISCHE VERFUEGBARKEIT VERSCHIEDENER DARREICHUNGSFORMEN VON TETRAZYKLINHYDROCHLORID = LA DISPONIBILITE BIOLOGIQUE DES DIVERSES FORMES DE CHLORHYDRATE DE TETRACYCLINEGUNDERT REMY U; BILZER W; LEHMANN HP et al.1974; PHARM. INDUSTR.; DTSCH.; DA. 1974; VOL. 36; NO 8; PP. 574-576; ABS. ANGL.; BIBL. 17REF.Article

NON-LINEAR ELIMINATION PROCESSES OF THEOPHYLLINEGUNDERT REMY U; HILDEBRANDT R; HENGEN N et al.1983; EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0031-6970; DEU; DA. 1983; VOL. 24; NO 1; PP. 71-78; BIBL. 19 REF.Article

NONLINEAR MEZLOCILLIN KINETICS DUE TO DOSE-DEPENDENT METABOLISMGUNDERT REMY U; HILDEBRANDT R; STIEHL A et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 5; PP. 656-662; BIBL. 18 REF.Article

THE PHARMACOKINETICS OF FURAZLOCILLIN IN HEALTHY HUMANSHINDERLING PH; GUNDERT REMY U; FORSTER D et al.1983; JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS; ISSN 0090-466X; USA; DA. 1983; VOL. 11; NO 1; PP. 5-30; BIBL. 2 P.Article

Hypokalaemia in pregnant women treated with the β₂-mimetic drug fenoterol : a concentration and time dependent effectHILDEBRANDT, R; WEITZEL, H.-K; GUNDERT-REMY, U et al.Journal of perinatal medicine. 1997, Vol 25, Num 2, pp 173-179, issn 0300-5577Article

ESTIMATION OF BILIARY EXCRETION OF UREIDOPENICILLINS IN HEALTHY VOLUNTEERS USING MARKER DILUTION TECHNIQUEGUNDERT REMY U; FROHNAPFEL F; JOURDAN W et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 6; PP. 795-801; BIBL. 10 REF.Article

Influence of theophylline on the renal clearance of erythromycinHILDEBRANDT, R; MÖLLER, H; GUNDERT-REMY, U et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1987, Vol 25, Num 11, pp 601-604, issn 0174-4879Article

Bioäquivalenz von Clonidin-Retardpräparaten mit Hilfe der Pharmakokinetik und Pharmakodynamik = Bioéquivalence de forme à libération contrôlée de la clonidine selon des paramètres pharmacocinétiques et pharmacodynamiques = Bioequivalence of controlled release preparations of clonidine using pharmacokinetics and pharmacodynamics parametersMÖLLER, H; GUNDERT-REMY, U; STÜBER, W et al.Pharmazeutische Industrie. 1985, Vol 47, Num 1, pp 93-98, issn 0031-711XArticle

ALTERED HYDROXYLATION RATE OF TRIAMTERENE IN PATIENTS WITH LIVER CIRRHOSISGUNDERT REMY U; MUELLER HERRMANN R; MUTSCHLER E et al.1982; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; ISSN 506508; DEU; DA. 1982; VOL. 20; NO 8; PP. 353-357; BIBL. 16 REF.Article

PLASMA AND URINARY LEVELS OF TRIAMTERENE AND CERTAIN METABOLITES AFTER ORAL ADMINISTRATION TO MANGUNDERT REMY U; VON KENNE D; WEBER E et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 16; NO 1; PP. 39-44; BIBL. 15 REF.Article

Clinical and statistical issues in therapeutic equivalence trialsGARBE, E; RÖHMEL, J; GUNDERT-REMY, U et al.European journal of clinical pharmacology. 1993, Vol 45, Num 1, pp 1-7, issn 0031-6970Article

The regulatory view on drug-drug interactionsMÜLLER, H.-J; GUNDERT-REMY, U.International journal of clinical pharmacology and therapeutics. 1994, Vol 32, Num 6, pp 269-273, issn 0946-1965Article

Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans..I: PharmacokineticsHINDERLING, P. H; GUNDERT-REMY, U; SCHMIDLIN, O et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 7, pp 703-710, issn 0022-3549Article

THE CLINICAL PHARMACOKINETICS OF BUFLOMEDIL IN NORMAL SUBJECTS AFTER INTRAVENOUS AND ORAL ADMINISTRATIONGUNDERT REMY U; WEBER E; LAM G et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 6; PP. 459-463; BIBL. 15 REF.Article

Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension : a population analysisMEINEKE, I; FELTKAMP, H; HÖGEMANN, A et al.European journal of clinical pharmacology. 1997, Vol 53, Num 3-4, pp 221-228, issn 0031-6970Article

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populationsALVAN, G; BECHTEL, P; ISELIUS, L et al.European journal of clinical pharmacology. 1990, Vol 39, Num 6, pp 533-537, issn 0031-6970, 5 p.Article

ZUR ERFASSUNG VON ARZNEIMITTELNEBENWIRKUNGEN IN EINER MEDIZINISCHEN UNIV.-KLINIK = EFFETS SECONDAIRES MEDICAMENTEUX OBSERVES DANS UNE CLINIQUE MEDICALE UNIVERSITAIREWEBER E; GUNDERT REMY U; HAHN KJ et al.1972; VERH. DTSCH. GESELLSCH. INNERE MED.; DTSCH.; DA. 1972; VOL. 78; PP. 1574-1577; BIBL. 6REF.Serial Issue

Pharmacokinetic criteria for drug research and developmentBALANT, L. P; ROSEBOOM, H; GUNDERT-REMY, U. M et al.Advances in Drug Research. 1990, Vol 19, pp 1-138, issn 0065-2490, 138 p.Article